Clinical Trial Update: Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemical renal sympatholysis with ethanol under CT guidance for therapy-resistant hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Resistant Hypertension

Drugs mentioned

• Ethanol (ethanol)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Hypertension Resistant to Conventional Therapy, Kidney Failure, Chronic | Phase 2 | Status: TERMINATED